Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,551 to 2,600 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.

    Acta scientiarum polonorum2016PMID 28071011

  • The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.

    Journal of obesity2016PMID 28101379

  • Beneficial effects of sitagliptin and metformin in non-diabetic hypertensive and dyslipidemic patients.

    Pakistan journal of pharmaceutical sciences2016PMID 28167482

  • Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.

    International journal of stroke2015PMID 23489282

  • Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.

    Journal of bone and mineral metabolism2015PMID 24633493

  • Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.

    Pediatric diabetes2015PMID 24698216

  • Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy.

    Journal of diabetes2015PMID 24823280

  • A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy.

    American journal of perinatology2015PMID 24896141

  • Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study.

    Diabetes, obesity & metabolism2015PMID 24919820

  • Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.

    Clinical endocrinology2015PMID 25130061

  • Effects of different doses of metformin treatment for 6 months on aberrant crypt foci in Chinese patients with impaired glucose tolerance.

    European journal of cancer prevention2015PMID 25162967

  • Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea.

    Diabetes, obesity & metabolism2015PMID 25175734

  • Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trial.

    Diabetes, obesity & metabolism2015PMID 25200570Indexed under metformin in PubMed's chemical list

  • Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.

    Diabetes care2015PMID 25205142

  • Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy.

    Diabetes care2015PMID 25216510

  • Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.

    Clinical gastroenterology and hepatology2015PMID 25218668

  • Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: the EASIE post-hoc analysis and extension trial.

    Journal of diabetes and its complications2015PMID 25283485

  • Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.

    Diabetes, obesity & metabolism2015PMID 25298165

  • Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome.

    Archives of gynecology and obstetrics2015PMID 25304269

  • Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.

    Endocrine journal2015PMID 25328079

  • Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.

    Pediatric diabetes2015PMID 25332100

  • Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

    Climacteric2015PMID 25333776

  • Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.

    Diabetes care2015PMID 25352655

  • Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.

    Diabetes, obesity & metabolism2015PMID 25359159Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis.

    Diabetes technology & therapeutics2015PMID 25369141

  • Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.

    Diabetic medicine2015PMID 25381876Indexed under metformin in PubMed's chemical list

  • Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.

    The Journal of clinical endocrinology and metabolism2015PMID 25393640Indexed under metformin in PubMed's chemical list

  • Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.

    Prostate cancer and prostatic diseases2015PMID 25403419

  • Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5.

    Diabetes, obesity & metabolism2015PMID 25406730

  • Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.

    Diabetes, obesity & metabolism2015PMID 25425451

  • Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.

    Diabetes & metabolic syndrome2015PMID 25450818

  • Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial.

    Diabetes research and clinical practice2015PMID 25467617

  • The effect of metformin on glucose homeostasis during moderate exercise.

    Diabetes care2015PMID 25468944

  • Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial.

    Diabetes, obesity & metabolism2015PMID 25475929

  • Effects of metformin on energy intake and satiety in obese children.

    Diabetes, obesity & metabolism2015PMID 25483291

  • The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial.

    Primary care diabetes2015PMID 25488587

  • Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension.

    Diabetes, obesity & metabolism2015PMID 25523633

  • The effects of metformin on weight loss in women with gestational diabetes: a pilot randomized, placebo-controlled trial.

    American journal of obstetrics and gynecology2015PMID 25526875

  • Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study.

    Cardiovascular therapeutics2015PMID 25545400

  • Pharmacokinetic study of metformin to compare voglibose/metformin fixed-dose combination with coadministered voglibose and metformin.

    International journal of clinical pharmacology and therapeutics2015PMID 25546164

  • Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.

    International journal of clinical pharmacology and therapeutics2015PMID 25546166

  • Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs.

    Archives of gynecology and obstetrics2015PMID 25547060

  • N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.

    European journal of clinical pharmacology2015PMID 25552403

  • Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus.

    Pharmacological reports2015PMID 25560571

  • Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients.

    Molecular diagnosis & therapy2015PMID 25573751

  • Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.

    Diabetes, obesity & metabolism2015PMID 25580775

  • Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review.

    Diabetic medicine2015PMID 25582542

  • Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.

    Diabetes care2015PMID 25583754Indexed under metformin in PubMed's chemical list

  • Efficacy of metformin in pregnant obese women: a randomised controlled trial.

    BMJ open2015PMID 25588785

  • Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.

    Diabetes care2015PMID 25592197

The next 50 papers

← Previous 50